Stereotactic ablative radiation therapy for oligometastatic prostate cancer delays time-to-next systemic treatment.
C Leigh MoyerRyan PhillipsMatthew P DeekNoura RadwanAshley E RossEmmanuel S AntonarakisDiane ReyesJean WrightStephanie A TerezakisDaniel Y SongCurtiland DeVillePatrick C WalshTheodore L DeWeeseMichael CarducciEdward M SchaefferKenneth J PientaMario EisenbergerPhuoc T TranPublished in: World journal of urology (2018)
Consolidative SABR in OPC is feasible and well tolerated. The heterogeneity and small size of our series limit extrapolation of clinically meaningful outcomes following consolidative SABR in OPC, but our preliminary data suggest that this approach warrants continued prospective study.